Nanjing Medlander Medical Technology Co (SHSE:688273) Enterprise Value: ¥3,219.3 Mil (As of Jul. 08, 2026) ***


SHSE:688273 Nanjing Medlander Medical Technology Co Ltd SHSE:688273
80 GF Score
Price ¥37.08
GF Value ¥35.04
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Nanjing Medlander Medical Technology Co Enterprise Value?

Nanjing Medlander Medical Technology Co SHSE:688273 -6.10% 80 Enterprise Value is ¥3,219.3 Mil as of Jul. 08, 2026. GuruFocus rates SHSE:688273 with a GF Score™ of 80/100 and a GF Value™ of ¥35.04 (Fairly Valued). The stock has 7 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Nanjing Medlander Medical Technology Co's Enterprise Value is ¥3,219.3 Mil. Nanjing Medlander Medical Technology Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ¥88.4 Mil. Therefore, Nanjing Medlander Medical Technology Co's EV-to-EBIT ratio for today is 36.41.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Nanjing Medlander Medical Technology Co's Enterprise Value is ¥3,219.3 Mil. Nanjing Medlander Medical Technology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ¥88.4 Mil. Therefore, Nanjing Medlander Medical Technology Co's EV-to-EBITDA ratio for today is 36.41.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Nanjing Medlander Medical Technology Co's Enterprise Value is ¥3,219.3 Mil. Nanjing Medlander Medical Technology Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ¥412.5 Mil. Therefore, Nanjing Medlander Medical Technology Co's EV-to-Revenue ratio for today is 7.80.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Nanjing Medlander Medical Technology Co's Enterprise Value is ¥3,219.3 Mil. Nanjing Medlander Medical Technology Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ¥92.9 Mil. Therefore, Nanjing Medlander Medical Technology Co's EV-to-OCF ratio for today is 34.63.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Nanjing Medlander Medical Technology Co's Enterprise Value is ¥3,219.3 Mil. Nanjing Medlander Medical Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥8.9 Mil. Therefore, Nanjing Medlander Medical Technology Co's EV-to-FCF ratio for today is 363.18.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Nanjing Medlander Medical Technology Co  (SHSE:688273) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Nanjing Medlander Medical Technology Co's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3219.270/88.421
=36.41

Nanjing Medlander Medical Technology Co's current Enterprise Value is ¥3,219.3 Mil.
Nanjing Medlander Medical Technology Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥88.4 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Nanjing Medlander Medical Technology Co's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=3219.270/88.421
=36.41

Nanjing Medlander Medical Technology Co's current Enterprise Value is ¥3,219.3 Mil.
Nanjing Medlander Medical Technology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥88.4 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Nanjing Medlander Medical Technology Co's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3219.270/412.516
=7.80

Nanjing Medlander Medical Technology Co's current Enterprise Value is ¥3,219.3 Mil.
Nanjing Medlander Medical Technology Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥412.5 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Nanjing Medlander Medical Technology Co's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=3219.270/92.949
=34.63

Nanjing Medlander Medical Technology Co's current Enterprise Value is ¥3,219.3 Mil.
Nanjing Medlander Medical Technology Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥92.9 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Nanjing Medlander Medical Technology Co's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3219.270/8.864
=363.18

Nanjing Medlander Medical Technology Co's current Enterprise Value is ¥3,219.3 Mil.
Nanjing Medlander Medical Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥8.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanjing Medlander Medical Technology Co Enterprise Value Related Terms


Nanjing Medlander Medical Technology Co Enterprise Value Historical Data

* Premium members only.

The historical data trend for Nanjing Medlander Medical Technology Co's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanjing Medlander Medical Technology Co Enterprise Value Chart

Nanjing Medlander Medical Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Enterprise Value
Get a 7-Day Free Trial 0.00 2,073.36 2,292.42 1,492.29 3,493.55

Nanjing Medlander Medical Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,009.72 2,276.64 3,305.01 3,493.55 3,025.27

SHSE:688273 vs ABT, SYK, MDT: Enterprise Value Comparison

For the Medical Devices subindustry, Nanjing Medlander Medical Technology Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanjing Medlander Medical Technology Co Enterprise Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nanjing Medlander Medical Technology Co's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Nanjing Medlander Medical Technology Co's Enterprise Value falls into.


SHSE:688273
80GF Score
Nanjing Medlander Medical Technology Co Ltd SHSE:688273
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanjing Medlander Medical Technology Co Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Nanjing Medlander Medical Technology Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Nanjing Medlander Medical Technology Co's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of ¥3,219.3 Mil mean?
Nanjing Medlander Medical Technology Co (SHSE:688273) has a Enterprise Value of ¥3,219.3 Mil as of Jul. 08, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Nanjing Medlander Medical Technology Co and its competitors.
Is Nanjing Medlander Medical Technology Co's Enterprise Value too high?
Nanjing Medlander Medical Technology Co's current Enterprise Value is ¥3,219.3 Mil. Overall, Nanjing Medlander Medical Technology Co has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nanjing Medlander Medical Technology Co's Enterprise Value compare to ABT and SYK?
Nanjing Medlander Medical Technology Co's Enterprise Value of ¥3,219.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Nanjing Medlander Medical Technology Co and its competitors. Nanjing Medlander Medical Technology Co's current Enterprise Value is ¥3,219.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanjing Medlander Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Nanjing Medlander Medical Technology Co (SHSE:688273) is currently considered Fairly Valued. The stock's GF Value™ is ¥35.04, compared to a current price of ¥37.08 — trading 5.8% above its estimated fair value. The current Enterprise Value is ¥3,219.3 Mil. Nanjing Medlander Medical Technology Co's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Nanjing Medlander Medical Technology Co (SHSE:688273), the current Enterprise Value is ¥3,219.3 Mil as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanjing Medlander Medical Technology Co (SHSE:688273) Overvalued in 2026?

Based on GuruFocus' analysis, Nanjing Medlander Medical Technology Co stock appears to be overvalued. The current stock price of ¥37.08 is trading 5.8% above its estimated GF Value™ of ¥35.04. GuruFocus considers Nanjing Medlander Medical Technology Co to be Fairly Valued.

Key valuation signals for SHSE:688273:

  • Enterprise Value: ¥3,219.3 Mil
  • GF Value™: ¥35.04 vs. price of ¥37.08 (5.8% above fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688273 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nanjing Medlander Medical Technology Co Business Description

Address Fengzhan Road, No. 32, Building A2, Yuhuatai District, Jiangsu Province, Nanjing, CHN, 210012
Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales, and service of related products in the field of pelvic floor and postpartum rehabilitation. Its products mainly include: biostimulation feedback instrument, color ultrasound diagnosis and evaluation system, magnetic stimulator, high-frequency evaluation electrocautery instrument, pelvic floor training instrument, portable postpartum recovery instrument, home pelvic floor rehabilitation therapy instrument, etc., which are widely used in obstetrics and gynecology, pelvic floor rehabilitation center, urology, anorectal department and other hospital departments.
80GF Score

Get the complete analysis for SHSE:688273

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥37.08
Price
¥35.04
GF Value